ACLX

Arcellx, Inc. - Common Stock (ACLX)

About Arcellx, Inc. - Common Stock (ACLX)

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Redwood City MD.

Details

Daily high

$70.44

Daily low

$67.58

Price at open

52 Week High

$107.37

52 Week Low

$47.86

Market cap

3.8B

Dividend yield

0.00%

Volume

401

Avg. volume

514,070

P/E ratio

-22.85

Arcellx, Inc. - Common Stock News